Literature DB >> 12084401

Risk factors for coronary artery disease in women.

Robert H Knopp1.   

Abstract

Because cardiovascular disease (CVD) is the most important cause of death in women in the United States, it is imperative that the main risk factors for CVD in women be identified and modified. The risk factors that have the strongest impact on the incidence of CVD in women are not necessarily the same as those for men. The risk for women increases at menopause, most likely because of the decrease in levels of circulating estrogen. The classic risk factor for CVD is altered lipid levels. In middle-aged women, elevated low-density lipoprotein cholesterol levels are somewhat less important relative to lowered levels of high-density lipoprotein cholesterol and elevated triglyceride levels as independent risk factors. The metabolic syndrome, which encompasses a range of conditions known to be CVD risk factors, also has a greater impact on the incidence of CVD in women than in men. Various emerging risk factors appear to be important indicators for vascular disease in women, including C-reactive protein, homocysteine, and lipoprotein(a) levels. Many of these risk factors are affected by hormone replacement therapy, which may diminish CVD risk in postmenopausal women. Because of the complex origin of CVD, it is important to target the full array of risk factors for modification, rather than focusing on a single factor or treatment to the exclusion of other important markers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084401     DOI: 10.1016/s0002-9149(02)02409-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Autonomic function and change in insulin for exercising postmenopausal women.

Authors:  Conrad P Earnest; Paul Poirier; Mercedes R Carnethon; Steven N Blair; Timothy S Church
Journal:  Maturitas       Date:  2010-03       Impact factor: 4.342

2.  Postprandial metabolic responses to dietary glycemic index in hypercholesterolemic postmenopausal women.

Authors:  Radhika N Bukkapatnam; Lars Berglund; Erdembileg Anuurad; Sridevi Devaraj; Dianne Hyson; Flora Rafii; Catharine Malmstein; Amparo C Villablanca
Journal:  Prev Cardiol       Date:  2010

3.  Novel hormone-regulated genes in visceral adipose tissue: cloning and identification of proinflammatory cytokine-like mouse and human MEDA-7: implications for obesity, insulin resistance and the metabolic syndrome.

Authors:  H Zhang; X Chen; M R Sairam
Journal:  Diabetologia       Date:  2011-06-19       Impact factor: 10.122

4.  Minor allele of the APOA4 gene T347S polymorphism predisposes to obesity in postmenopausal Turkish women.

Authors:  Filiz Guclu-Geyik; Altan Onat; Neslihan Coban; Evrim Komurcu-Bayrak; Vedat Sansoy; Günay Can; Nihan Erginel-Unaltuna
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

Review 5.  Molecular studies on coronary artery disease-a review.

Authors:  A Supriya Simon; T Vijayakumar
Journal:  Indian J Clin Biochem       Date:  2013-02-12

6.  Androgenicity and venous endothelial function in post-menopausal women.

Authors:  M A Maturana; M C Rubira; F Consolim-Colombo; M C Irigoyen; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2009-10-09       Impact factor: 4.256

7.  Risk prediction-Homocysteine in Coronary Heart Disease.

Authors:  Rao B Harish; V Govindaraju; C N Manjunath
Journal:  Indian J Clin Biochem       Date:  2007-03

Review 8.  Menopause, the metabolic syndrome, and mind-body therapies.

Authors:  Kim E Innes; Terry Kit Selfe; Ann Gill Taylor
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

9.  Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan.

Authors:  Wuan-Szu Wang; Mark L Wahlqvist; Chih-Cheng Hsu; Hsing-Yi Chang; Wan-Chi Chang; Chu-Chih Chen
Journal:  BMC Public Health       Date:  2012-02-10       Impact factor: 3.295

10.  Using simultaneous equation modeling for defining complex phenotypes.

Authors:  Terri M King
Journal:  BMC Genet       Date:  2003-12-31       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.